SonoScape Founding
SonoScape was born and set sail for the future
2002
Ultrasound
Endoscopy
Minimally Invasive Surgery
Motivated by our goal and innovation, we planned from the beginning to have global R&D centers across the world. Since our founding we have established R&D centers in Shenzhen, Shanghai, Wuhan, Tuttlingen, Tokyo, San Francisco and Seattle. Integrating global advanced technologies and resources, we are continuously investing into our R&D, and maintaining the advantages in our core technologies. We are introducing more accurate and efficient medical solutions through innovation in technology, and providing a higher quality medical solutions for the patients.
As a diverse team of scientists, medical experts, researchers and product designers, we will keep creating and developing products and technologies for medical applications. Delivering accurate and efficient medical solutions needed by doctors of today and tomorrow.
Looking to the future, we shall continue to dedicate ourselves to deliver meaningful and accessible medical solutions for the benefit of patients and doctors alike.
2023 SonoScape is recognized by the National Development and Reform Commission as
2023 SonoScape Medical Corp. Central Lab obtained
2021 SonoScape X5
2021 China Medical Devices Industrial Data Release Conference
2020 Participate in setting
2019 HD-550、HD-500 Enter into
2017
in Endoscopy Diagnosis Field
by Frost & Sullivan
in Ultrasound Diagnosis Field
by Frost & Sullivan
2014 IF
by Frost & Sullivan
Reddot 2011
by Frost & Sullivan
by Frost & Sullivan
SonoScape was born and set sail for the future
The 15-inch LCD large screen color Doppler ultrasound system in China
SonoScape products could be found across globe in many countries and regions
Completed the establishment of offices and subsidiaries in China
SonoScape experienced significant growth to meet the demands of the market
In addition to a variety of ultrasound products, SonoScape developed endoscopy and in vitro diagnostic product lines
Received “Company of the Year in Ultrasound Market, 2014” by Frost & Sullivan
Through continuous invest into independent research and development SonoScape was uplifted to become one of the world’s key ultrasound manufacturers
SonoScape's HD-500 Electronic Endoscopy System surged onto the market
Became the company making both ultrasound and endoscopy technologies to be listed on the Shenzhen Stock Exchange
Three CMOS 4K ultra-high-definition rigid scope
SonoScape became the first company in China to master the core technology of EUS
SonoScape donated medical devices to support frontline battles against Covid-19
SonoScape X5 was aboard to deliver ultrasound imaging in Space
S-Fetus 4.0, the first obstetric screening technology based on deep learning launched globally
Multiple products obtained the CE-Mark under EU-MDR
SonoScape's cutting-edge HD-580 Endoscopy System has been announced
SonoScape is recognized by the National Development and Reform Commission as National Enterprise Technology Center
SonoScape Medical Corp. Central Lab obtained China National Accreditation Service for Conformity Assessment (CNAS) Laboratory Accreditation Certificate